Keeping Current CME

Mar 31, 2025

How much do you know about HER2 alterations in patients with non-small cell lung cancer (NSCLC)?

Credit available for this activity expires: 3/31/2026
Learning Objectives & Disclosures:

Mar 31, 2025

Now that we have approved disease-modifying therapies for Alzheimer’s disease (AD), what is the best way to work with patients, families, and colleagues to administer them?

Learning Objectives & Disclosures: 

Mar 31, 2025

How do the eligibility criteria for the monarchE and NATALEE clinical trials compare?

Learning Objectives & Disclosures: 

Mar 31, 2025

Learn from experts the rationale behind different clinical trial designs and how to interpret their findings.

Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002400

Mar 25, 2025

Explore the data showing us that hypercortisolism is more common than expected in cases of difficult-to-control diabetes and hypertension.

Credit available for this activity expires: 3/21/26
Earn Credit / Learning Objectives & Disclosures: